@GlasgowCC it's not only the city centre, ....bottles, tissues and plastics are thrown everywhere in this city! People caught should be paying a heavy fine just like paying parking tickets....
@DrSamuelBHume 1, red blood cells are heavily sialyated and will be a big sink for the drug; 2, NK cells are scarce in solid tumours and macrophages mostly MDSCs. The likelihood of this working is low.
@BBCBreakfast@BBCPolitics If labor cares about working class people, they should allow business to survive so people can be employed. Butt they have strangled businesses.
@anandbmdphd In our analysis of 20 AML patient samples (not published), there are CD45low, SSClow AML blasts that are CD123 negative. So even if the CD123 positive blasts are killed, the CD123 negative ones will grow up. CD123 is simply not a good choice of targets.
@Rfonsi1 we have done a lot of preclinical studies using SP34 as a reference, but our results have not published yet. In brief, we noted that use of bispecific antibodies using SP34 (at a higher dosage) resulted in much reduced human T cell counts in animal models.
@Rfonsi1 would be interesting to know T cell status in patients following treatment. Teclistamab is using a very strong T cell agonist (SP34) which tend to over stimulate and result in activation induced T cell death.
@RahulBanerjeeMD would like to see patient T cell analysis after TEC . TEC is using SP34, a very strong T cell agonist that in vitro can drive T cell activation at a very low concentration. wouldn't be surprised if T cells are exhausted or die (activation induced cell death-AICD)